Ebola virus disease
Open accessThe DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Abstract
Ebola virus disease (EVD) is a severe and frequently lethal disease caused by Ebola virus (EBOV). EVD outbreaks typically start from a single case of probable zoonotic transmission, followed by human-to-human transmission via direct contact or contact with infected bodily fluids or contaminated fomites. EVD has a high case–fatality rate; it is characterized by fever, gastrointestinal signs and multiple organ dysfunction syndrome. Diagnosis requires a combination of case definition and laboratory tests, typically real-time reverse transcription PCR to detect viral RNA or rapid diagnostic tests based on immunoassays to detect EBOV antigens. Recent advances in medical countermeasure research resulted in the recent approval of an EBOV-targeted vaccine by European and US regulatory agencies. The results of a randomized clinical trial of investigational therapeutics for EVD demonstrated survival benefits from two monoclonal antibody products targeting the EBOV membrane glycoprotein. New observations emerging from the unprecedented 2013–2016 Western African EVD outbreak (the largest in history) and the ongoing EVD outbreak in the Democratic Republic of the Congo have substantially improved the understanding of EVD and viral persistence in survivors of EVD, resulting in new strategies toward prevention of infection and optimization of clinical management, acute illness outcomes and attendance to the clinical care needs of patients. Ebola virus disease (EVD) is caused by the filovirus Ebola virus (EBOV). Although the natural host of EBOV is undefined, a single zoonotic transmission is the probable start of most EVD outbreaks. EVD is characterized by gastrointestinal manifestations and multiple organ dysfunction syndrome and has a high case–fatality rate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections
WHO Ebola Response Team (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1411100 · Cited by 1,674
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Mulangu, S., Dodd, L. E., Davey, R. T., Tshiani Mbaya, O., Proschan, M., Mukadi, D., Lusakibanza Manzo, M., Nzolo, D., Tshomba Oloma, A., Ibanda, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910993 · Cited by 1,605
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Warren, T. K., Jordan, R., Lo, M. K., Ray, A. S., Mackman, R. L., Soloveva, V., Siegel, D., Perron, M., Bannister, R., Hui, H. C., et al. (2016) · Nature · doi:10.1038/nature17180 · Cited by 1,556
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
Carette, J. E., Raaben, M., Wong, A. C., Herbert, A. S., Obernosterer, G., Mulherkar, N., Kuehne, A. I., Kranzusch, P. J., Griffin, A. M., Ruthel, G., et al. (2011) · Nature · doi:10.1038/nature10348 · Cited by 1,303
Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak
Gire, S. K., Goba, A., Andersen, K. G., Sealfon, R. S. G., Park, D. J., Kanneh, L., Jalloh, S., Momoh, M., Fullah, M., Dudas, G., et al. (2014) · Science · doi:10.1126/science.1259657 · Cited by 1,215
Henao-Restrepo, A. M., Camacho, A., Longini, I. M., Watson, C. H., Edmunds, W. J., Egger, M., Carroll, M. W., Dean, N. E., Diatta, I., Doumbia, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32621-6 · Cited by 1,110
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Qiu, X., Wong, G., Audet, J., Bello, A., Fernando, L., Alimonti, J. B., Fausther-Bovendo, H., Wei, H., Aviles, J., Hiatt, E., et al. (2014) · Nature · doi:10.1038/nature13777 · Cited by 987
Henao-Restrepo, A. M., Longini, I. M., Egger, M., Dean, N. E., Edmunds, W. J., Camacho, A., Carroll, M. W., Doumbia, M., Draguez, B., Duraffour, S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61117-5 · Cited by 793
Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection
Côté, M., Misasi, J., Ren, T., Bruchez, A., Lee, K., Filone, C. M., Hensley, L., Li, Q., Ory, D., Chandran, K., et al. (2011) · Nature · doi:10.1038/nature10380 · Cited by 686
Hoarau, J.-J., Jaffar Bandjee, M.-C., Krejbich Trotot, P., Das, T., Li-Pat-Yuen, G., Dassa, B., Denizot, M., Guichard, E., Ribera, A., Henni, T., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900255 · Cited by 640
Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques
Geisbert, T. W., Hensley, L. E., Larsen, T., Young, H. A., Reed, D. S., Geisbert, J. B., Scott, D. P., Kagan, E., Jahrling, P. B., & Davis, K. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63591-2 · Cited by 576
A system for functional analysis of Ebola virus glycoprotein
Takada, A., Robison, C., Goto, H., Sanchez, A., Murti, K. G., Whitt, M. A., & Kawaoka, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14764 · Cited by 575
Chowell, G., Hengartner, N. W., Castillo-Chavez, C., Fenimore, P. W., & Hyman, J. M. (2004) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2004.03.006 · Cited by 571
Baize, S., Leroy, E. M., Georges-Courbot, M.-C., Capron, M., Lansoud-Soukate, J., Debré, P., Fisher-Hoch, S. P., McCormick, J. B., & Georges, A. J. (1999) · Nature Medicine · doi:10.1038/7422 · Cited by 551
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea
van Griensven, J., Edwards, T., de Lamballerie, X., Semple, M. G., Gallian, P., Baize, S., Horby, P. W., Raoul, H., Magassouba, N., Antierens, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1511812 · Cited by 536
Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone
Schieffelin, J. S., Shaffer, J. G., Goba, A., Gbakie, M., Gire, S. K., Colubri, A., Sealfon, R. S. G., Kanneh, L., Moigboi, A., Momoh, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1411680 · Cited by 530
Assessment of the Risk of Ebola Virus Transmission from Bodily Fluids and Fomites
Bausch, D. G., Towner, J. S., Dowell, S. F., Kaducu, F., Lukwiya, M., Sanchez, A., Nichol, S. T., Ksiazek, T. G., & Rollin, P. E. (2007) · The Journal of Infectious Diseases · doi:10.1086/520545 · Cited by 522
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
The PREVAIL II Writing Group (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604330 · Cited by 520
A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
Bray, M., Davis, K., Geisbert, T., Schmaljohn, C., & Huggins, J. (1998) · The Journal of Infectious Diseases · doi:10.1086/515386 · Cited by 492
The Ebola virus VP35 protein functions as a type I IFN antagonist
Basler, C. F., Wang, X., Mühlberger, E., Volchkov, V., Paragas, J., Klenk, H.-D., García-Sastre, A., & Palese, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220398297 · Cited by 478
Sissoko, D., Laouenan, C., Folkesson, E., M’Lebing, A.-B., Beavogui, A.-H., Baize, S., Camara, A.-M., Maes, P., Shepherd, S., Danel, C., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1001967 · Cited by 478
The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3
Basler, C. F., Mikulasova, A., Martinez-Sobrido, L., Paragas, J., Mühlberger, E., Bray, M., Klenk, H.-D., Palese, P., & García-Sastre, A. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.7945-7956.2003 · Cited by 477
Persistence of Ebola Virus in Ocular Fluid during Convalescence
Varkey, J. B., Shantha, J. G., Crozier, I., Kraft, C. S., Lyon, G. M., Mehta, A. K., Kumar, G., Smith, J. R., Kainulainen, M. H., Whitmer, S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500306 · Cited by 470
Self-citationBwaka, M. A., Bonnet, M., Calain, P., Colebunders, R., De Roo, A., Guimard, Y., Katwiki, K. R., Kibadi, K., Kipasa, M. A., Kuvula, K. J., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514308 · Cited by 465
Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation
Reid, S. P., Leung, L. W., Hartman, A. L., Martinez, O., Shaw, M. L., Carbonnelle, C., Volchkov, V. E., Nichol, S. T., & Basler, C. F. (2006) · Journal of Virology · doi:10.1128/jvi.02349-05 · Cited by 463
Cárdenas, W. B., Loo, Y.-M., Gale, M., Hartman, A. L., Kimberlin, C. R., Martínez-Sobrido, L., Saphire, E. O., & Basler, C. F. (2006) · Journal of Virology · doi:10.1128/jvi.02199-05 · Cited by 453
Molecular Evidence of Sexual Transmission of Ebola Virus
Mate, S. E., Kugelman, J. R., Nyenswah, T. G., Ladner, J. T., Wiley, M. R., Cordier-Lassalle, T., Christie, A., Schroth, G. P., Gross, S. M., Davies-Wayne, G. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509773 · Cited by 434
Self-citationProtective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
Corti, D., Misasi, J., Mulangu, S., Stanley, D. A., Kanekiyo, M., Wollen, S., Ploquin, A., Doria-Rose, N. A., Staupe, R. P., Bailey, M., et al. (2016) · Science · doi:10.1126/science.aad5224 · Cited by 408
Virus genomes reveal factors that spread and sustained the Ebola epidemic
Dudas, G., Carvalho, L. M., Bedford, T., Tatem, A. J., Baele, G., Faria, N. R., Park, D. J., Ladner, J. T., Arias, A., Asogun, D., et al. (2017) · Nature · doi:10.1038/nature22040 · Cited by 405
Self-citationDowell, S. F., Mukunu, R., Ksiazek, T. G., Khan, A. S., Rollin, P. E., Peters, C. J., & the Commission de Lutte contre les Epidémies à Kikwit (1999) · The Journal of Infectious Diseases · doi:10.1086/514284 · Cited by 398
Chow, A., Her, Z., Ong, E. K. S., Chen, J.-M., Dimatatac, F., Kwek, D. J. C., Barkham, T., Yang, H., Rénia, L., Leo, Y.-S., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq042 · Cited by 389
Rowe, A. K., Bertolli, J., Khan, A. S., Mukunu, R., Muyembe‐Tamfum, J. J., Bressler, D., Williams, A. J., Peters, C. J., Rodriguez, L., Feldmann, H., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514318 · Cited by 387
Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea
Bah, E. I., Lamah, M.-C., Fletcher, T., Jacob, S. T., Brett-Major, D. M., Sall, A. A., Shindo, N., Fischer, W. A., Lamontagne, F., Saliou, S. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411249 · Cited by 386
Self-citationEbola RNA Persistence in Semen of Ebola Virus Disease Survivors — Final Report
Deen, G. F., Broutet, N., Xu, W., Knust, B., Sesay, F. R., McDonald, S. L. R., Ervin, E., Marrinan, J. E., Gaillard, P., Habib, N., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1511410 · Cited by 375
ISOLATION AND PARTIAL CHARACTERISATION OF A NEW VIRUS CAUSING ACUTE HÆMORRHAGIC FEVER IN ZAIRE
Johnson, K. M., Lange, J. V., Webb, P. A., & Murphy, F. A. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92000-1 · Cited by 372
Geisbert, T. W., Young, H. A., Jahrling, P. B., Davis, K. J., Kagan, E., & Hensley, L. E. (2003) · The Journal of Infectious Diseases · doi:10.1086/379724 · Cited by 372
Clinical Management of Ebola Virus Disease in the United States and Europe
Uyeki, T. M., Mehta, A. K., Davey, R. T., Liddell, A. M., Wolf, T., Vetter, P., Schmiedel, S., Grünewald, T., Jacobs, M., Arribas, J. R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1504874 · Cited by 368
Self-citationLate Ebola virus relapse causing meningoencephalitis: a case report
Jacobs, M., Rodger, A., Bell, D. J., Bhagani, S., Cropley, I., Filipe, A., Gifford, R. J., Hopkins, S., Hughes, J., Jabeen, F., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30386-5 · Cited by 361
Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses
Mahanty, S., Hutchinson, K., Agarwal, S., Mcrae, M., Rollin, P. E., & Pulendran, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.2797 · Cited by 354
Ebola Virus Disease in West Africa — Clinical Manifestations and Management
Chertow, D. S., Kleine, C., Edwards, J. K., Scaini, R., Giuliani, R., & Sprecher, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1413084 · Cited by 350
Clinical Care of Two Patients with Ebola Virus Disease in the United States
Lyon, G. M., Mehta, A. K., Varkey, J. B., Brantly, K., Plyler, L., McElroy, A. K., Kraft, C. S., Towner, J. S., Spiropoulou, C., Ströher, U., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409838 · Cited by 337
Self-citationTetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein
Kaletsky, R. L., Francica, J. R., Agrawal-Gamse, C., & Bates, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811014106 · Cited by 335
Milligan, I. D., Gibani, M. M., Sewell, R., Clutterbuck, E. A., Campbell, D., Plested, E., Nuthall, E., Voysey, M., Silva-Reyes, L., McElrath, M. J., et al. (2016) · JAMA · doi:10.1001/jama.2016.4218 · Cited by 324
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses
Martines, R. B., Ng, D. L., Greer, P. W., Rollin, P. E., & Zaki, S. R. (2015) · The Journal of Pathology · doi:10.1002/path.4456 · Cited by 319
Ebola Virus Disease in the Democratic Republic of Congo
Maganga, G. D., Kapetshi, J., Berthet, N., Kebela Ilunga, B., Kabange, F., Mbala Kingebeni, P., Mondonge, V., Muyembe, J.-J. T., Bertherat, E., Briand, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1411099 · Cited by 316
Rodriguez, L. L., De Roo, A., Guimard, Y., Trappier, S. G., Sanchez, A., Bressler, D., Williams, A. J., Rowe, A. K., Bertolli, J., Khan, A. S., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514291 · Cited by 311
Human Ebola virus infection results in substantial immune activation
McElroy, A. K., Akondy, R. S., Davis, C. W., Ellebedy, A. H., Mehta, A. K., Kraft, C. S., Lyon, G. M., Ribner, B. S., Varkey, J., Sidney, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502619112 · Cited by 306
Self-citationTemporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa
Carroll, M. W., Matthews, D. A., Hiscox, J. A., Elmore, M. J., Pollakis, G., Rambaut, A., Hewson, R., García-Dorival, I., Bore, J. A., Koundouno, R., et al. (2015) · Nature · doi:10.1038/nature14594 · Cited by 302
Apoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses
Geisbert, T. W., Hensley, L. E., Gibb, T. R., Steele, K. E., Jaax, N. K., & Jahrling, P. B. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780021 · Cited by 302
An outbreak of Ebola in Uganda
Okware, S. I., Omaswa, F. G., Zaramba, S., Opio, A., Lutwama, J. J., Kamugisha, J., Rwaguma, E. B., Kagwa, P., & Lamunu, M. (2002) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2002.00944.x · Cited by 300
Bosio, C. M., Aman, M. J., Grogan, C., Hogan, R., Ruthel, G., Negley, D., Mohamadzadeh, M., Bavari, S., & Schmaljohn, A. (2003) · The Journal of Infectious Diseases · doi:10.1086/379199 · Cited by 296
Human Infection Due to Ebola Virus, Subtype Côte d'Ivoire: Clinical and Biologic Presentation
Formenty, P., Hatz, C., Le Guenno, B., Stoll, A., Rogenmoser, P., & Widmer, A. (1999) · The Journal of Infectious Diseases · doi:10.1086/514285 · Cited by 283
Huttner, A., Dayer, J.-A., Yerly, S., Combescure, C., Auderset, F., Desmeules, J., Eickmann, M., Finckh, A., Goncalves, A. R., Hooper, J. W., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00154-1 · Cited by 272
Bray, M., & Geisbert, T. W. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.02.018 · Cited by 265
Diallo, B., Sissoko, D., Loman, N. J., Bah, H. A., Bah, H., Worrell, M. C., Conde, L. S., Sacko, R., Mesfin, S., Loua, A., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw601 · Cited by 263
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia
Kennedy, S. B., Bolay, F., Kieh, M., Grandits, G., Badio, M., Ballou, R., Eckes, R., Feinberg, M., Follmann, D., Grund, B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614067 · Cited by 251
Reid, S. P., Valmas, C., Martinez, O., Sanchez, F. M., & Basler, C. F. (2007) · Journal of Virology · doi:10.1128/jvi.01097-07 · Cited by 248
Hensley, L. (2002) · Immunology Letters · doi:10.1016/s0165-2478(01)00327-3 · Cited by 242
Prins, K. C., Cárdenas, W. B., & Basler, C. F. (2009) · Journal of Virology · doi:10.1128/jvi.01875-08 · Cited by 241
Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study
Clark, D. V., Kibuuka, H., Millard, M., Wakabi, S., Lukwago, L., Taylor, A., Eller, M. A., Eller, L. A., Michael, N. L., Honko, A. N., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70152-0 · Cited by 236
Wolf, T., Kann, G., Becker, S., Stephan, C., Brodt, H.-R., de Leuw, P., Grünewald, T., Vogl, T., Kempf, V. A. J., Keppler, O. T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62384-9 · Cited by 230
Transmission of Ebola Viruses: What We Know and What We Do Not Know
Osterholm, M. T., Moore, K. A., Kelley, N. S., Brosseau, L. M., Wong, G., Murphy, F. A., Peters, C. J., LeDuc, J. W., Russell, P. K., Van Herp, M., et al. (2015) · mBio · doi:10.1128/mbio.00137-15 · Cited by 225
Human Adaptation of Ebola Virus during the West African Outbreak
Urbanowicz, R. A., McClure, C. P., Sakuntabhai, A., Sall, A. A., Kobinger, G., Müller, M. A., Holmes, E. C., Rey, F. A., Simon-Loriere, E., & Ball, J. K. (2016) · Cell · doi:10.1016/j.cell.2016.10.013 · Cited by 221
Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35
Leung, D. W., Prins, K. C., Borek, D. M., Farahbakhsh, M., Tufariello, J. M., Ramanan, P., Nix, J. C., Helgeson, L. A., Otwinowski, Z., Honzatko, R. B., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1765 · Cited by 210
Caring for Critically Ill Patients with Ebola Virus Disease. Perspectives from West Africa
Fowler, R. A., Fletcher, T., Fischer, W. A., Lamontagne, F., Jacob, S., Brett-Major, D., Lawler, J. V., Jacquerioz, F. A., Houlihan, C., O’Dempsey, T., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201408-1514cp · Cited by 209
Self-citationZur Ätiologie einer unbekannten, von Affen ausgegangenen menschlichen Infektionskrankheit
Siegert, R., Shu, H.-L., Slenczka, W., Peters, D., & Müller, G. (1967) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0028-1106144 · Cited by 207
Ebola’s mental-health wounds linger in Africa
Reardon, S. (2015) · Nature · doi:10.1038/519013a · Cited by 205
Hunt, L., Gupta-Wright, A., Simms, V., Tamba, F., Knott, V., Tamba, K., Heisenberg-Mansaray, S., Tamba, E., Sheriff, A., Conteh, S., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00144-9 · Cited by 204
FILOVIRUSES - A COMPENDIUM OF 40 YEARS OF EPIDEMIOLOGICAL, CLINICAL, AND LABORATORY STUDIES
Kuhn, J. H., & Calisher, C. H. (2008) · PubMed · doi:10.13140/2.1.1683.5365 · Cited by 200
Self-citationISOLATION OF MARBURG-LIKE VIRUS FROM A CASE OF HÆMORRHAGIC FEVER IN ZAIRE
Pattyn, S., Groen, G. V., Jacob, W., Piot, P., & Courteille, G. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92002-5 · Cited by 196
Kraft, C. S., Hewlett, A. L., Koepsell, S., Winkler, A. M., Kratochvil, C. J., Larson, L., Varkey, J. B., Mehta, A. K., Lyon, G. M., Friedman-Moraco, R. J., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ334 · Cited by 195
Self-citationEbola Virus Glycoprotein with Increased Infectivity Dominated the 2013–2016 Epidemic
Diehl, W. E., Lin, A. E., Grubaugh, N. D., Carvalho, L. M., Kim, K., Kyawe, P. P., McCauley, S. M., Donnard, E., Kucukural, A., McDonel, P., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.014 · Cited by 195
Gupta, M., Mahanty, S., Ahmed, R., & Rollin, P. E. (2001) · Virology · doi:10.1006/viro.2001.0836 · Cited by 192
Unique human immune signature of Ebola virus disease in Guinea
Ruibal, P., Oestereich, L., Lüdtke, A., Becker-Ziaja, B., Wozniak, D. M., Kerber, R., Korva, M., Cabeza-Cabrerizo, M., Bore, J. A., Koundouno, F. R., et al. (2016) · Nature · doi:10.1038/nature17949 · Cited by 182
Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study
Mattia, J. G., Vandy, M. J., Chang, J. C., Platt, D. E., Dierberg, K., Bausch, D. G., Brooks, T., Conteh, S., Crozier, I., Fowler, R. A., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00489-2 · Cited by 180
Self-citationDisease modeling for Ebola and Marburg viruses
Bente, D., Gren, J., Strong, J. E., & Feldmann, H. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.000471 · Cited by 179
Luthra, P., Ramanan, P., Mire, C. E., Weisend, C., Tsuda, Y., Yen, B., Liu, G., Leung, D. W., Geisbert, T. W., Ebihara, H., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.06.010 · Cited by 179
A Longitudinal Study of Ebola Sequelae in Liberia
The PREVAIL III Study Group (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1805435 · Cited by 177
Possible sexual transmission of Ebola virus - Liberia, 2015.
Christie, A., Davies-Wayne, G., Cordier-Lassalle, T., Cordier-Lasalle, T., Blackley, D. J., Laney, A. S., Williams, D. E., Shinde, S. A., Badio, M., Lo, T., et al. (2015) · PubMed Central · Cited by 176
Pascal, K. E., Dudgeon, D., Trefry, J. C., Anantpadma, M., Sakurai, Y., Murin, C. D., Turner, H. L., Fairhurst, J., Torres, M., Rafique, A., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy285 · Cited by 175
Feng, Z., Cerveny, M., Yan, Z., & He, B. (2007) · Journal of Virology · doi:10.1128/jvi.01006-06 · Cited by 174
Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection
Davis, C. W., Jackson, K. J. L., McElroy, A. K., Halfmann, P., Huang, J., Chennareddy, C., Piper, A. E., Leung, Y., Albariño, C. G., Crozier, I., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.036 · Cited by 171
Self-citationEbola Hemorrhagic Fever and Pregnancy
Mupapa, K., Mukundu, W., Bwaka, M. A., Kipasa, M., De Roo, A., Kuvula, K., Kibadi, K., Massamba, M., Ndaberey, D., Colebunders, R., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514289 · Cited by 165
Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial
Dunning, J., Sahr, F., Rojek, A., Gannon, F., Carson, G., Idriss, B., Massaquoi, T., Gandi, R., Joseph, S., Osman, H. K., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1001997 · Cited by 165
Genetic diversity and evolutionary dynamics of Ebola virus in Sierra Leone
Tong, Y.-G., Shi, W.-F., Liu, D., Qian, J., Liang, L., Bo, X.-C., Liu, J., Ren, H.-G., Fan, H., Ni, M., et al. (2015) · Nature · doi:10.1038/nature14490 · Cited by 164
Structure of the Ebola VP35 interferon inhibitory domain
Leung, D. W., Ginder, N. D., Fulton, D. B., Nix, J. C., Basler, C. F., Honzatko, R. B., & Amarasinghe, G. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807854106 · Cited by 161
Animal models for Ebola and Marburg virus infections
Nakayama, E., & Saijo, M. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00267 · Cited by 159
Mohammed, A., Sheikh, T. L., Gidado, S., Poggensee, G., Nguku, P., Olayinka, A., Ohuabunwo, C., Waziri, N., Shuaib, F., Adeyemi, J., et al. (2015) · BMC Public Health · doi:10.1186/s12889-015-2167-6 · Cited by 159
Social Pathways for Ebola Virus Disease in Rural Sierra Leone, and Some Implications for Containment
Richards, P., Amara, J., Ferme, M. C., Kamara, P., Mokuwa, E., Sheriff, A. I., Suluku, R., & Voors, M. (2015) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0003567 · Cited by 158
Evidence-based guidelines for supportive care of patients with Ebola virus disease
Lamontagne, F., Fowler, R. A., Adhikari, N. K., Murthy, S., Brett-Major, D. M., Jacobs, M., Uyeki, T. M., Vallenas, C., Norris, S. L., Fischer, W. A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)31795-6 · Cited by 158
Self-citationEbola Virus Disease Complications as Experienced by Survivors in Sierra Leone
Tiffany, A., Vetter, P., Mattia, J. G., Dayer, J.-A., Bartsch, M., Kasztura, M., Sterk, E., Tijerino, A. M., Kaiser, L., & Ciglenečki, I. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw158 · Cited by 156
A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
Bray, M., Davis, K., Geisbert, T., Schmaljohn, C. S., & Huggins, J. W. (1999) · The Journal of Infectious Diseases · doi:10.1086/514292 · Cited by 153
Roels, T. H., Bloom, A. S., Buffington, J., Muhungu, G. L., Kenzie, W. R. M., Khan, A. S., Ndambi, R., Noah, D. L., Rolka, H. R., Peters, C. J., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514286 · Cited by 151
Rollin, P. E., Bausch, D. G., & Sanchez, A. (2007) · The Journal of Infectious Diseases · doi:10.1086/520613 · Cited by 149
Geisbert, T. W., Strong, J. E., & Feldmann, H. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv284 · Cited by 144
First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease
Dörnemann, J., Burzio, C., Ronsse, A., Sprecher, A., Clerck, H. D., Herp, M. V., Kolié, M.-C., Yosifiva, V., Caluwaerts, S., McElroy, A. K., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw493 · Cited by 138
Kibadi, K., Mupapa, K., Kuvula, K., Massamba, M., Ndaberey, D., Muyembe‐Tamfum, J. J., Bwaka, M. A., Roo, A. D., & Colebunders, R. (1999) · The Journal of Infectious Diseases · doi:10.1086/514288 · Cited by 134
Ebola: limitations of correcting misinformation
Chandler, C., Fairhead, J. R., Kelly, A. H., Leach, M., Martineau, F., Mokuwa, E. Y., Parker, M., Richards, P. M., & Wilkinson, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)62382-5 · Cited by 132
Ebola viral load at diagnosis associates with patient outcome and outbreak evolution
Vega, M.-A. D. L., Caleo, G., Audet, J., Qiu, X., Kozak, R. A., Brooks, J., Kern, S. E., Wolz, A., Sprecher, A., Greig, J. E., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83162 · Cited by 131
Self-citationHeterogeneities in the case fatality ratio in the West African Ebola outbreak 2013–2016
Garske, T., Cori, A., Ariyarajah, A., Blake, I. M., Dorigatti, I., Eckmanns, T., Fraser, C., Hinsley, W. R., Jombart, T., Mills, H. L., et al. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0308 · Cited by 130
Ebola Virus Disease among Children in West Africa
WHO Ebola Response Team (2015) · New England Journal of Medicine · doi:10.1056/nejmc1415318 · Cited by 129
Mora-Rillo, M., Arsuaga, M., Olivencia, G. R., Calle, F., Borobia, A. M., Sánchez-Seco, P., Lago, M., Figueira, J. C., Fernández-Puntero, B., Viejo, A., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00180-0 · Cited by 128
The role of rapid diagnostics in managing Ebola epidemics
Nouvellet, P., Garske, T., Mills, H. L., Nedjati-Gilani, G. L., Hinsley, W. R., Blake, I. M., Kerkhove, M. D. V., Cori, A., Dorigatti, I., Jombart, T., et al. (2015) · Nature · doi:10.1038/nature16041 · Cited by 128
Gaudinski, M. R., Coates, E. E., Novik, L., Widge, A. T., Houser, K. V., Burch, E., Holman, L. A., Gordon, I. J., Chen, G. L., Carter, C., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30036-4 · Cited by 128
Arias, A., Watson, S. J., Asogun, D., Tobin, E. A., Lu, J., Phan, M. V. T., Jah, U., Wadoum, R. E. G., Meredith, L., Thorne, L., et al. (2016) · Virus Evolution · doi:10.1093/ve/vew016 · Cited by 124
Étard, J.-F., Sow, M., Leroy, S., Touré, A. F., Taverne, B., Kéita, A. K., Msellati, P., Magassouba, N., Baize, S., Raoul, H., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30516-3 · Cited by 123
Measuring the impact of Ebola control measures in Sierra Leone
Kucharski, A. J., Camacho, A., Flasche, S., Glover, R. E., Edmunds, W. J., & Funk, S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508814112 · Cited by 122
Multi-platform ’Omics Analysis of Human Ebola Virus Disease Pathogenesis
Eisfeld, A. J., Halfmann, P., Wendler, J., Kyle, J. E., Burnum-Johnson, K., Peralta, Z., Maemura, T., Walters, K., Watanabe, T., Fukuyama, S., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.10.011 · Cited by 117
Lado, M., Walker, N. F., Baker, P., Haroon, S. M., Brown, C. S., Youkee, D., Studd, N., Kessete, Q., Maini, R., Boyles, T. H., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00137-1 · Cited by 116
Spermatogene Übertragung des „Virus Marburg“
Martini, G. A., & Schmidt, H. (1968) · Journal of Molecular Medicine · doi:10.1007/bf01734141 · Cited by 114
Harcourt, B. H., Sanchez, A., & Offermann, M. K. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3491-3496.1999 · Cited by 113
Fitzpatrick, G., VOGT, F. M., Gbabai, O., Decroo, T., Keane, M., Clerck, H. D., Grolla, A., Brechard, R., Stinson, K., & Herp, M. V. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv304 · Cited by 113
Pigott, D. M., Deshpande, A., Letourneau, I. D., Morozoff, C., Reiner, R. C., Kraemer, M. U. G., Brent, S. E., Bogoch, I. I., Khan, K., Biehl, M. H., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32092-5 · Cited by 113
Self-citationEffect of Artesunate–Amodiaquine on Mortality Related to Ebola Virus Disease
Gignoux, E., Azman, A. S., de Smet, M., Azuma, P., Massaquoi, M., Job, D., Tiffany, A., Petrucci, R., Sterk, E., Potet, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1504605 · Cited by 112
Ebola and Marburg virus-like particles activate human myeloid dendritic cells
Bosio, C. M., Moore, B. D., Warfield, K. L., Ruthel, G. T., Mohamadzadeh, M., Aman, M. J., & Bavari, S. (2004) · Virology · doi:10.1016/j.virol.2004.05.025 · Cited by 111
Study of Ebola Virus Disease Survivors in Guinea: Table 1.
Qureshi, A. I., Chughtai, M., Loua, T. O., Pe Kolie, J., Camara, H. F. S., Ishfaq, M. F., N'Dour, C. T., & Beavogui, K. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ453 · Cited by 111
Barry, A., Ahuka‐Mundeke, S., Ahmed, Y. A., Allarangar, Y., Anoko, J. N., Archer, B. N., Abedi, A. A., Bagaria, J., Bélizaire, M. R. D., Bhatia, S., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31387-4 · Cited by 111
Post-Ebola Syndrome, Sierra Leone
Scott, J. T., Sesay, F. R., Massaquoi, T. A., Idriss, B. R., Sahr, F., & Semple, M. G. (2016) · Emerging infectious diseases · doi:10.3201/eid2204.151302 · Cited by 108
Outbreaks of Ebola virus disease in Africa: the beginnings of a tragic saga
Chippaux, J. (2014) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1186/1678-9199-20-44 · Cited by 105
Persistence and Sexual Transmission of Filoviruses
Schindell, B. G., Webb, A. L., & Kindrachuk, J. (2018) · Viruses · doi:10.3390/v10120683 · Cited by 101
Efficacy of Convalescent Plasma in Relation to Dose of Ebola Virus Antibodies
van Griensven, J., Edwards, T., & Baize, S. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1609116 · Cited by 100
van Griensven, J., Weggheleire, A. D., Délamou, A., Smith, P. G., Edwards, T., Vandekerckhove, P. G., Bah, E. I., Colebunders, R., Isola, H., Lazaygues, C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ680 · Cited by 94
Dean, N. E., Halloran, M. E., Yang, Y., & Longini, I. M. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw114 · Cited by 94
Ebola Virus Inhibits Induction of Genes by Double-Stranded RNA in Endothelial Cells
Harcourt, B. H., Sanchez, A., & Offermann, M. K. (1998) · Virology · doi:10.1006/viro.1998.9446 · Cited by 93
Clinical Features of Patients With Ebola Virus Disease in Sierra Leone
Qin, E., Bi, J., Zhao, M., Wang, Y., Guo, T., Yan, T., Li, Z., Sun, J., Zhang, J., Suhong, C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ319 · Cited by 93
Bebell, L. M., Oduyebo, T., & Riley, L. E. (2017) · Birth Defects Research · doi:10.1002/bdra.23558 · Cited by 91
Wahl‐Jensen, V., Kurz, S. K., Feldmann, F., Buehler, L. K., Kindrachuk, J., DeFilippis, V. R., Correia, J. D. S., Früh, K., Kuhn, J. H., Burton, D. R., et al. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001359 · Cited by 90
Self-citationKingebeni, P. M., Aziza, A., Paola, N. D., Wiley, M. R., Mandanda, S. M., Caviness, K., Pratt, C. B., Ladner, J. T., Kugelman, J. R., Prieto, K., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30118-5 · Cited by 90
Self-citationFiloviruses: Ecology, Molecular Biology, and Evolution
Emanuel, J., Marzi, A., & Feldmann, H. (2018) · Advances in virus research · doi:10.1016/bs.aivir.2017.12.002 · Cited by 88
Plasma lipidome reveals critical illness and recovery from human Ebola virus disease
Kyle, J. E., Burnum-Johnson, K., Wendler, J., Eisfeld, A. J., Halfmann, P., Watanabe, T., Sahr, F., Smith, R. D., Kawaoka, Y., Waters, K. M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815356116 · Cited by 87
Ecological Contexts of Index Cases and Spillover Events of Different Ebolaviruses
Judson, S. D., Fischer, R. J., Judson, A., & Munster, V. J. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005780 · Cited by 85
Subissi, L., Keïta, M., Mesfin, S., Rezza, G., Diallo, B., Gucht, S. V., Musa, E. O., Yoti, Z., Keïta, S., Djingarey, M. H., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy280 · Cited by 85
Management of pregnant women infected with Ebola virus in a treatment centre in Guinea, June 2014
Baggi, F., Taybi, A., Kurth, A. A., Herp, M. V., Di, A., Wölfel, R., Günther, S., Decroo, T., Declerck, H., & Jonckheere, S. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.49.20983 · Cited by 83
Huttner, A. C., Agnandji, S. T., Combescure, C., Fernandes, J. F., Bache, E. B., Kabwende, A. L., Ndungu, F. M., Brosnahan, J. S., Monath, T. P. C., Lemaître, B., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30165-8 · Cited by 82
A new player in the puzzle of filovirus entry
White, J. M., & Schornberg, K. L. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2764 · Cited by 81
Successful Delivery of RRT in Ebola Virus Disease
Connor, M. J., Jr., Kraft, C. S., Mehta, A. K., Varkey, J. B., Lyon, G. M., Crozier, I., Ströher, U., Ribner, B. S., & Franch, H. A. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111057 · Cited by 78
Self-citationEthical and Practical Considerations in Providing Critical Care to Patients With Ebola Virus Disease
Torabi‐Parizi, P., Davey, R. T., Suffredini, A. F., & Chertow, D. S. (2015) · CHEST Journal · doi:10.1378/chest.15-0278 · Cited by 78
Ocular Complications in Survivors of the Ebola Outbreak in Guinea
Hereth-Hebert, E., Bah, M. O., Étard, J.-F., Sow, M., Resnikoff, S., Fardeau, C., Touré, A. F., Ouendeno, N. A., Sagno, C., March, L., et al. (2016) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2016.12.005 · Cited by 78
Vernet, M.-A., Reynard, S., Fizet, A., Schaeffer, J., Pannetier, D., Guedj, J., Rives, M., Georges, N., Garcia-Bonnet, N., Sylla, A. I., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.88864 · Cited by 77
Insights from clinical research completed during the west Africa Ebola virus disease epidemic
Rojek, A. M., Horby, P., & Dunning, J. W. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30234-7 · Cited by 77
Shantha, J. G., Crozier, I., Hayek, B., Bruce, B. B., Gargu, C., Brown, J., Fankhauser, J., & Yeh, S. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.10.011 · Cited by 76
Self-citationEbola VP40 in Exosomes Can Cause Immune Cell Dysfunction
Pleet, M. L., Mathiesen, A., DeMarino, C., Akpamagbo, Y. A., Barclay, R. A., Schwab, A., Iordanskiy, S., Sampey, G. C., Lepene, B., Ilinykh, P. A., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01765 · Cited by 74
Winslow, R., Milligan, I. D., Voysey, M., Lühn, K., Shukarev, G., Douoguih, M., & Snape, M. D. (2017) · JAMA · doi:10.1001/jama.2016.20644 · Cited by 72
Minimally Symptomatic Infection in an Ebola ‘Hotspot’: A Cross-Sectional Serosurvey
Richardson, E. T., Kelly, J. D., Barrie, M. B., Mesman, A. W., Karku, S., Quiwa, K., Marsh, R. H., Koedoyoma, S., Daboh, F., Barron, K., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005087 · Cited by 71
Particle-to-PFU Ratio of Ebola Virus Influences Disease Course and Survival in Cynomolgus Macaques
Alfson, K. J., Avena, L. E., Beadles, M. W., Staples, H. M., Nunneley, J. W., Ticer, A. E., Dick, E. J., Owston, M. A., Reed, C. D., Patterson, J. L., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00649-15 · Cited by 69
Self-citationGatiso, T. T., Ordaz‐Németh, I., Grimes, T., Lormie, M. M., Tweh, C. G., Kühl, H. S., & Junker, J. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006580 · Cited by 69
Post-Traumatic Stress Reactions in Ebola Virus Disease Survivors in Sierra Leone
Hugo, M., Declerck, H., Fitzpatrick, G., Severy, N., Gbabai, O., Decroo, T., & Herp, M. V. (2015) · Emergency Medicine Open Access · doi:10.4172/2165-7548.1000285 · Cited by 65
Dilemmas in Managing Pregnant Women With Ebola: 2 Case Reports: Table 1.
Caluwaerts, S., Fautsch, T., Lagrou, D., Moreau, M., Camara, A. M., Günther, S., Di, A., Borremans, B., Koundouno, F. R., Boré, J. A., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ1024 · Cited by 63
An update on ocular complications of Ebola virus disease
Shantha, J. G., Crozier, I., & Yeh, S. (2017) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000426 · Cited by 63
Self-citationFunctional Characterization of Adaptive Mutations during the West African Ebola Virus Outbreak
Dietzel, E., Schudt, G., Krähling, V., Matrosovich, M. N., & Becker, S. (2016) · Journal of Virology · doi:10.1128/jvi.01913-16 · Cited by 62
Ebola vaccination in the Democratic Republic of the Congo
Wells, C. R., Pandey, A., Parpia, A. S., Fitzpatrick, M. C., Meyers, L. A., Singer, B. H., & Galvani, A. P. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1817329116 · Cited by 62
Bower, H., Johnson, S., Bangura, M. S., Kamara, A. J., Kamara, O., Mansaray, S. H., Sesay, D., Turay, C., Checchi, F., & Glynn, J. R. (2016) · Emerging infectious diseases · doi:10.3201/eid2208.160163 · Cited by 61
Ebola Virus Disease in Humans: Pathophysiology and Immunity
Muñoz‐Fontela, C., & McElroy, A. K. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_11 · Cited by 61
Marzi, A., Chadinah, S., Haddock, E., Feldmann, F., Arndt, N., Martellaro, C., Scott, D. P., Hanley, P. W., Nyenswah, T., Sow, S. O., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.027 · Cited by 61
Ebola Virus Infection Associated with Transmission from Survivors
den Boon, S., Marston, B. J., Nyenswah, T., et al. (2018) · Emerging infectious diseases · doi:10.3201/eid2502.181011 · Cited by 61
Biochemical Basis for Increased Activity of Ebola Glycoprotein in the 2013–16 Epidemic
Wang, M. K., Lim, S.-Y., Lee, S. M., & Cunningham, J. M. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.02.002 · Cited by 59
Sequelae of Ebola Virus Disease, Kenema District, Sierra Leone
Nanyonga, M., Saidu, J., Ramsay, A., Shindo, N., & Bausch, D. G. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ795 · Cited by 58
Time From Infection to Disease and Infectiousness for Ebola Virus Disease, a Systematic Review
Velásquez, G. E., Aibana, O., Ling, E. J., Diakite, I., Mooring, E. Q., & Murray, M. B. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ531 · Cited by 57
Waxman, M. A., Aluisio, A. R., Rege, S., & Levine, A. C. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30112-3 · Cited by 57
Lamb, L., Cox, A., Fletcher, T. E., & McCourt, A. (2016) · Journal of the Royal Army Medical Corps · doi:10.1136/jramc-2015-000615 · Cited by 55
Epidemiology and Risk Factors for Ebola Virus Disease in Sierra Leone—23 May 2014 to 31 January 2015
Dietz, P. M., Jambai, A., Paweska, J. T., Yoti, Z., & Ksaizek, T. G. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ568 · Cited by 53
Johnson, D. W., Sullivan, J. N., Piquette, C. A., Hewlett, A. L., Bailey, K. L., Smith, P. W., Kalil, A. C., & Lisco, S. J. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000000935 · Cited by 53
Self-citationLevine, A. C., Shetty, P., Burbach, R., Cheemalapati, S., Glavis‐Bloom, J., Wiskel, T., & Kesselly, J. K. T. (2015) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2015.03.011 · Cited by 49
Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement
Sagui, E., Janvier, F., Baize, S., Foissaud, V., Koulibaly, F., Savini, H., Maugey, N., Aletti, M., Granier, H., & Carmoi, T. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ606 · Cited by 48
Kingebeni, P. M., Pratt, C. B., Wiley, M. R., Diagne, M. M., Mandanda, S. M., Aziza, A., Paola, N. D., Chitty, J. A., Diop, M., Ayouba, A., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30124-0 · Cited by 48
Self-citationWoolsey, C. B., Menicucci, A. R., Cross, R. W., Luthra, P., Agans, K. N., Borisevich, V., Geisbert, J. B., Mire, C. E., Fenton, K. A., Jankeel, A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.047 · Cited by 47
Ebola virus-mediated T-lymphocyte depletion is the result of an abortive infection
Younan, P. M., Santos, R. I., Ramanathan, P., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008068 · Cited by 47
Ebola hemorrhagic fever: why were children spared?
Dowell, S. F. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199603000-00002 · Cited by 46
Lactating mothers infected with Ebola virus: EBOV RT-PCR of blood only may be insufficient
Moreau, M., Spencer, C., Gozalbes, J. G., Colebunders, R., Lefèvre, A., Gryseels, S., Borremans, B., Günther, S., Becker, D., Boré, J. A., et al. (2015) · Eurosurveillance · doi:10.2807/1560-7917.es2015.20.3.21017 · Cited by 46
Ebola control: rapid diagnostic testing
Dhillon, R. S., Srikrishna, D., Garry, R. F., & Chowell, G. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)71035-7 · Cited by 46
Bower, H., Grass, J. E., Veltus, E. F., Brault, A. C., Campbell, S., Basile, A. J., Wang, D., Paddock, C. D., Erickson, B. R., Salzer, J. S., et al. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0619 · Cited by 46
O’Shea, M. K., Clay, K. A., Craig, D. G. N., Matthews, S., Kao, R. L. C., Fletcher, T. E., Bailey, M. S., & Hutley, E. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ399 · Cited by 45
Clinical Predictors of Mortality in Patients With Ebola Virus Disease
Barry, M., Touré, A. F., Traoré, F., Sako, F. B., Sylla, D., Kpamy, D. O., Bah, E. I., Bangoura, M., Poncin, M., Keita, S., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ202 · Cited by 42
The Role of Exosomal VP40 in Ebola Virus Disease
Pleet, M. L., DeMarino, C., Lepene, B. S., Aman, M. J., & Kashanchi, F. (2017) · DNA and Cell Biology · doi:10.1089/dna.2017.3639 · Cited by 42
Carroll, M. W., Haldenby, S. T., Rickett, N. Y., Pályi, B., García-Dorival, I., Liu, X. E., Barker, G., Boré, J. A., Koundouno, F. R., Williamson, E. D., et al. (2017) · mSphere · doi:10.1128/mspheredirect.00325-17 · Cited by 41
Critical Care for Multiple Organ Failure Secondary to Ebola Virus Disease in the United States*
Sueblinvong, V., Johnson, D. W., Weinstein, G. L., Connor, M. J., Jr., Crozier, I., Liddell, A. M., Franch, H. A., Wall, B. R., Kalil, A. C., Feldman, M. L., et al. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001197 · Cited by 40
Self-citationvan den Pol, A. N., Mao, G., Chattopadhyay, A., Rose, J. K., & Davis, J. N. (2017) · Journal of Virology · doi:10.1128/jvi.02154-16 · Cited by 39
Smit, M. A., Michelow, I. C., Glavis‐Bloom, J., Wolfman, V., & Levine, A. C. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw725 · Cited by 38
Wannier, R., Worden, L., Hoff, N. A., Amezcua, E., Selo, B., Sinai, C., Mossoko, M., Njoloko, B., Okitolonda-Wemakoy, E., Kingebeni, P. M., et al. (2019) · Epidemics · doi:10.1016/j.epidem.2019.100353 · Cited by 37
Cournac, J. M., Karkowski, L., Bordes, J., Aletti, M., Duron, S., Janvier, F., Foissaud, V., Savini, H., de Greslan, T., Rousseau, C., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ779 · Cited by 36
Potential Impact of Sexual Transmission on Ebola Virus Epidemiology: Sierra Leone as a Case Study
Abbate, J. L., Murall, C. L., Richner, H., & Althaus, C. L. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004676 · Cited by 35
Ebola Virus–Related Encephalitis: Table 1.
de Greslan, T., Billhot, M., Rousseau, C., Nab, C. M., Karkowski, L., Cournac, J.-M., Bordes, J., Gagnon, N., Dubrous, P., Duron, S., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw469 · Cited by 35
Impact of spatial dispersion, evolution and selection on Ebola Zaire Virus epidemic waves
Azarian, T., Presti, A. L., Giovanetti, M., Cella, E., Magalis, B. R., Lai, A., Zehender, G., Ciccozzi, M., & Salemi, M. (2015) · Scientific Reports · doi:10.1038/srep10170 · Cited by 34
Shah, T., Greig, J. E., van der Plas, L. M., Achar, J., Caleo, G., Squire, J. S., Turay, A. S., Joshy, G., D’Este, C. A., Banks, E., et al. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30097-3 · Cited by 34
Dodd, L. E., Follmann, D. A., Proschan, M. A., Wang, J., Malvy, D. J.-M., van Griensven, J., Ciglenečki, I., Horby, P., Ansumana, R., Jiang, J., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1049 · Cited by 33
Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease
Chancellor, J. R., Padmanabhan, S. P., Greenough, T. C., Sacra, R., Ellison, R. T., Madoff, L. C., Droms, R. J., Hinkle, D. M., Asdourian, G. K., Finberg, R. W., et al. (2015) · Emerging infectious diseases · doi:10.3201/eid2202.151416 · Cited by 32
Live neonates born to mothers with Ebola virus disease: a review of the literature
Nelson, J. M., Griese, S. E., Goodman, A. B., et al. (2015) · Journal of Perinatology · doi:10.1038/jp.2015.189 · Cited by 31
Shifting the Paradigm — Applying Universal Standards of Care to Ebola Virus Disease
Fischer, W. A., Crozier, I., Bausch, D. G., Muyembe, J., Mulangu, S., Diaz, J. V., Kojan, R., Wohl, D. A., & Jacob, S. T. (2019) · New England Journal of Medicine · doi:10.1056/nejmp1817070 · Cited by 30
Self-citationKasereka, M. C., & Hawkes, M. (2019) · Pathogens and Global Health · doi:10.1080/20477724.2019.1650227 · Cited by 30
(2008) · Springer eBooks · doi:10.1007/978-3-211-69495-4_1 · Cited by 30
Age-specific incidence of Ebola virus disease
Glynn, J. R. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61446-5 · Cited by 28
Thromboelastography in the Management of Coagulopathy Associated With Ebola Virus Disease
Wilson, A. J., MARTIN, D. S., Maddox, V., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ977 · Cited by 27
Timothy, J. W. S., Hall, Y., Boré, J. A., Diallo, B., Tipton, T. R. W., Bower, H., Strecker, T., Glynn, J. R., & Carroll, M. W. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30791-6 · Cited by 27
Ebola Immunity: Gaining a Winning Position in Lightning Chess
Ploquin, A., Zhou, Y., & Sullivan, N. J. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700827 · Cited by 26
Xu, Z., Jin, B., Teng, G., Rong, Y., Sun, L., Zhang, J., Du, N., Liu, L., Su, H., Yuan, Y., et al. (2016) · American Journal of Infection Control · doi:10.1016/j.ajic.2016.04.216 · Cited by 24
West African Ebola crisis and orphans
Evans, D. K., & Popova, A. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60179-9 · Cited by 22
Auffermann, W. F., Kraft, C. S., Vanairsdale, S., Lyon, G. M., & Tridandapani, S. (2014) · American Journal of Roentgenology · doi:10.2214/ajr.14.14041 · Cited by 22
Self-citationMoving Towards a More Aggressive and Comprehensive Model of Care for Children with Ebola
Trehan, I., Kelly, T., Marsh, R. H., George, P. M., & Callahan, C. W. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.11.054 · Cited by 19
Ebola virus disease in children during the 2014–2015 epidemic in Guinea: a nationwide cohort study
Chérif, M. S., Koonrungsesomboon, N., Kassé, D., Cissé, S. D., Diallo, S. B., Chérif, F., Camara, F., Koné, A., Avenido, E. F., Diakité, M., et al. (2017) · European Journal of Pediatrics · doi:10.1007/s00431-017-2914-z · Cited by 18
Cited by
Looking beyond COVID-19 vaccine phase 3 trials
Kim, J. H., Marks, F., & Clemens, J. D. (2021) · Nature Medicine · doi:10.1038/s41591-021-01230-y · Cited by 585
Geldsetzer, P. (2020) · Journal of Medical Internet Research · doi:10.2196/18790 · Cited by 504
Vaccine development for emerging infectious diseases
Excler, J.-L., Saville, M., Berkley, S., & Kim, J. H. (2021) · Nature Medicine · doi:10.1038/s41591-021-01301-0 · Cited by 410
Nanoparticle Size Effects in Biomedical Applications
Dolai, J., Mandal, K., & Jana, N. R. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c00987 · Cited by 358
Viral sepsis: diagnosis, clinical features, pathogenesis, and clinical considerations
Xu, J.-Q., Zhang, W.-Y., Fu, J.-J., Fang, X.-Z., Gao, C.-G., Li, C., Yao, L., Li, Q.-L., Yang, X.-B., Ren, L.-H., et al. (2024) · Military Medical Research · doi:10.1186/s40779-024-00581-0 · Cited by 37
Metadata
- Authors
- Jacob, S. T., Crozier, I., Fischer, W. A., Hewlett, A., Kraft, C. S., Vega, M.-A. D. L., Soka, M. J., Wahl, V., Griffiths, A., Bollinger, L., & Kuhn, J. H.
- Venue
- Nature Reviews Disease Primers
- Published
- 2020-02-20
- Volume
- 6
- Issue
- 1
- Pages
- 13-13
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4211119126
- Cited by
- 664
- References
- 209
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.